Manav Maini

Manav Maini

Active Director Director DIN 02434303
DIN 02434303 First appointment Nov 2008 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Nov 2008
Shareholding value Locked Premium profile

About Manav Maini

Manav Maini has 17 years in corporate governance. Holds Director role. Currently with 1 company, including Grampus Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02434303
Primary Designation Director
First Appointment 17 Nov 2008
Oldest Company Age 25 yrs

Current companies

Company Designation Appointment Founded Status
Director 17 Nov 2008 2001 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Grampus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Manav Maini

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manav Maini

Manav Maini has 17 years in corporate governance. Holds Director role. Currently with 1 company, including Grampus Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Manav Maini is associated with 1 company as Director.

Manav Maini has expertise in General Business.

Manav Maini has 17 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available